FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma CANCER MED-US
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study BLOOD CANCER J
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries FRONT MED-LAUSANNE
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study HEMATOL ONCOL
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia BLOOD ADV
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion CANCER GENE THER
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors FRONT IMMUNOL
Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients Haematologica
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms bioRxiv